Human intelligence enhanced by artificial intelligence
A revolution in cardiovascular identification and management
How are you reducing heart failure readmissions?
How are you managing your cardiovascular patient population?
How do you know if a structural heart patient has been missed?
How are you reducing heart failure readmissions?
How are you managing your cardiovascular patient population?
How do you know if a structural heart patient has been missed?
Human intelligence enhanced by artificial intelligence
A revolution in cardiovascular identification and management
The Solution 
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
The Leading Cardiovascular Platform Has Expanded Into Atrial Fibrillation:
Aortic
Stenosis
Mitral
Stenosis
Tricuspid
Regurgitation
Heart
Failure
Aortic
Regurgitation
Mitral
Regurgitation
Atrial
Fibrillation
Aortic
Stenosis
Mitral
Stenosis
Tricuspid
Regurgitation
Heart
Failure
Aortic
Regurgitation
Mitral
Regurgitation
Atrial
Fibrillation
Aortic
Stenosis
Aortic
Regurgitation
Mitral
Stenosis
Mitral
Regurgitation
Tricuspid
Regurgitation
Heart
Failure
Atrial
Fibrillation
The Challenge
Taking On the Challenge
CardioCare is a digital health platform to help hospitals manage cardiovascular patients by focusing on:
Reducing Morbidity
& Mortality
Help physicians identify patients early to help prevent death, stroke & hospitalizations
Increasing Guideline-Directed Therapy
Increase appropriate referrals to CV specialists
Standardizing
Quality
Understand variability in the care pathway from echo exams to referral patterns
The Challenge
Taking On the Challenge
CardioCare is a digital health platform to help hospitals manage cardiovascular patients by focusing on:
Reducing Morbidity
& Mortality
Help physicians identify patients early to help prevent death, stroke & hospitalizations
Increasing Guideline-Directed Therapy
Increase appropriate referrals to CV specialists
Standardizing
Quality
Understand variability in the care pathway from echo exams to referral patterns
The Solution
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
How it Works
Artificial Intelligence Solutions Elevating the Standard of Care Across the Cardiovascular Service Line
The CardioCare platform is a single-source solution that leverages artificial intelligence and big data analytics, helping hospital systems prioritize resources to identify patients who would benefit from guideline-directed therapy.
Big Data
Leveraging AI from millions of records to help you understand your hospital's entire cardiovascular population
Insights On Demand
Prioritizing care for patients eligible for life saving treatment
Artificial Intelligence Algorithms
Helping physicians identify patients with a higher likelihood of having undiagnosed severe disease
* The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of cardiovascular diseases.
Testimonials
Leading hospitals partner with egnite’s CardioCare platform to reduce variability in care and improve guideline-directed therapy for patients with cardiovascular disease.
Swedish Medical Center
Director of Structural Interventions, Stanford Health Care
Senior Medical Advisor, egnite
Resources
Using AI and Big Data to Speed Up Cardiovascular Clinical Trials
Clinical trials are necessary to ensure the safety and efficacy of new therapies, but they can be time-consuming, costly and inefficient to enroll, slowing down access to lifesaving treatment options. The future of faster clinical trials is here.
egnite, Inc. and JenaValve Announce Strategic Partnership to Uncover Trends in Care for Patients with Aortic Regurgitation
Partnership aims to understand the care paradigm and associated outcomes for patients with aortic regurgitation. First study presented by Nick Amoroso, MD, at the TVT Structural Heart Summit in Phoenix, Arizona.
egnite, Inc. Announces Research from its Real-World Database at Heart Rhythm 2023
Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting. Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy.